Management of mixed dementia.
Alzheimer's disease (AD) and vascular dementia (VaD) are the most common causes of dementia in the elderly. Although AD can be diagnosed with a considerable degree of accuracy, the distinction between isolated AD, VaD and mixed dementia (MD) [when both pathologies coexist in the same patient] remains a controversial issue and one of the most difficult diagnostic challenges. MD represents a very common pathology, especially in the elderly, as reported in neuropathological studies. Accurate diagnosis of MD is of crucial significance for epidemiological purposes and for preventive and therapeutic strategies. Until recently, pharmacological studies have generally focused on pure disease, either AD or VaD, and have provided few data on the best therapeutic approach to MD. There is only one original randomized clinical trial on (acetyl)cholinesterase inhibitor therapy (GAL-INT-6, galantamine) for MD; the other studies are post hoc analyses of AD trial subgroups (AD2000, donepezil) or of VaD trial subgroups (VantagE, rivastigmine). Cholinesterase inhibitors have reproducible beneficial effects on cognitive and functional outcomes in patients with MD. These benefits are of a similar magnitude to those previously reported for the treatment of AD. It is likely that the beneficial effects of memantine (an NMDA receptor antagonist) in AD may also apply to MD, but randomized controlled trials are still lacking. Treatment of cardiovascular risk factors, especially hypertension, may protect brain function and should be included in prevention strategies for MD.
Zekry
Dina
D
Rehabilitation and Geriatrics Department, Geneva University, Thônex, Switzerland. dina.zekry@hcuge.ch
Gold
Gabriel
G
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy / Q000517:prevention & control; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003704:Dementia / Q000188:drug therapy* / Q000517:prevention & control; D015140:Dementia, Vascular / Q000188:drug therapy / Q000517:prevention & control; D015259:Dopamine Agents / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors
D002800:Cholinesterase Inhibitors; D015259:Dopamine Agents
Acta Neuropathol. 2002 May;103(5):481-7
11935264
Brain. 2007 Nov;130(Pt 11):2830-6
17878206
Int Psychogeriatr. 2009 Apr;21(2):359-68
19250558
Arch Gen Psychiatry. 2005 Feb;62(2):217-24
15699299
Stroke. 1992 Jun;23(6):798-803
1595095
Circulation. 2005 Sep 13;112(11):1644-50
16145004
Lancet Neurol. 2007 Sep;6(9):782-92
17689146
Neurology. 2001 Dec 26;57(12):2229-35
11756602
Neurology. 1998 Jul;51(1 Suppl 1):S45-52; discussion S65-7
9674762
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD004034
19821318
Int Clin Psychopharmacol. 2002 Nov;17(6):297-305
12409683
Lancet. 1997 Sep 13;350(9080):757-64
9297994
N Engl J Med. 2003 Apr 3;348(14):1333-41
12672860
Neurology. 2005 Jan 25;64(2):277-81
15668425
J Neurol Sci. 2007 Jun 15;257(1-2):80-7
17324442
J Neural Transm (Vienna). 2002 May;109(5-6):813-36
12111471
J Neural Transm (Vienna). 1996;103(10):1211-20
9013408
Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S22-32
9236949
Lancet. 2004 Jun 26;363(9427):2105-15
15220031
Am J Geriatr Psychiatry. 1997 Fall;5(4):279-83
9363284
Arch Neurol. 2005 Jul;62(7):1047-51
16009757
J Am Geriatr Soc. 2009 Oct;57(10):1934-5
19807793
Neurology. 2007 Mar 20;68(12):927-31
17372128
Postgrad Med J. 1985 Mar;61(713):201-4
3983054
Stroke. 1997 Mar;28(3):526-30
9056606
J Hypertens Suppl. 2006 Mar;24(1):S107-14
16601563
Neurology. 2005 Nov 8;65(9):1388-94
16275825
Stroke. 2002 Jul;33(7):1834-9
12105362
Clin Ther. 2003 Jun;25(6):1765-82
12860497
Stroke. 2007 Dec;38(12):3182-5
17962598
Neurology. 2001 May 8;56(9):1154-66
11342679
Neuroepidemiology. 1995;14(5):240-57
7477666
Int J Clin Pract. 2003 Nov;57(9):756-60
14686563
Arch Neurol. 1997 Jan;54(1):33-9
9006411
Clin Ther. 1989 Jul-Aug;11(4):545-54
2776169
Drugs Aging. 2006;23(3):241-9
16608379
Stroke. 1987 Jan-Feb;18(1):138-41
3810746
Lancet. 2002 Apr 13;359(9314):1283-90
11965273
N Engl J Med. 2006 Aug 10;355(6):549-59
16899775
Neuroepidemiology. 1998;17(1):2-9
9549718
JAMA. 1991 Jun 26;265(24):3255-64
2046107
Acta Neurol Scand. 1989 May;79(5):397-406
2568069
J Neurol Neurosurg Psychiatry. 2009 May;80(5):478-83
19211595
Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S106-14
10609689
Neurobiol Aging. 2000 Mar-Apr;21(2):153-60
10867200
Blood Press. 2006;15(2):71-9
16754269
Dementia. 1994 May-Aug;5(3-4):137-44
8087168
Neurobiol Aging. 2001 May-Jun;22(3):407-12
11378246
J Am Geriatr Soc. 2002 Aug;50(8):1431-8
12165002
Neurology. 1993 Feb;43(2):250-60
8094895
Int J Clin Pract. 2009 Jul;63(7):1061-7
19570123
Acta Neuropathol. 2007 Jan;113(1):1-12
17036244
J Psychopharmacol. 2008 Sep;22(7):761-8
18308781
Stroke. 1996 Mar;27(3):520-5; discussion 525-6
8610323
Int J Epidemiol. 1991;20 Suppl 2:S4-12
1833353
J Am Geriatr Soc. 1993 Jan;41(1):31-7
8418119
Eur Neurol. 1998 Oct;40(3):121-9
9748669
JAMA. 2004 Dec 15;292(23):2901-8
15598922
Neurology. 2001 May 8;56(9):1143-53
11342678
J Neurol Sci. 2007 Jun 15;257(1-2):17-22
17321551
Am J Psychiatry. 1984 Nov;141(11):1356-64
6496779
Neurology. 1994 Dec;44(12):2308-14
7991117
Eur J Neurol. 2003 Nov;10(6):633-40
14641507
Dementia. 1994 May-Aug;5(3-4):163-7
8087172
Lancet. 1996 Apr 27;347(9009):1141-5
8609748
Dement Geriatr Cogn Disord. 2007;24(2):73-81
17565216
Lancet. 1998 Oct 24;352(9137):1347-51
9802273
Lancet. 2002 Jul 6;360(9326):7-22
12114036
Lancet. 2002 Nov 23;360(9346):1623-30
12457784
Lancet Neurol. 2008 Aug;7(8):683-9
18614402
J Neurol Sci. 2002 Nov 15;203-204:131-6
12417371
N Engl J Med. 2008 May 1;358(18):1887-98
18378519
Neuroepidemiology. 2006;27(2):101-16
16943684
Int Psychogeriatr. 2003;15 Suppl 1:215-7
16191243
Stroke. 1997 Feb;28(2):459-63
9040707
Toxicology. 2000 Nov 16;153(1-3):167-78
11090955
Neurology. 1984 Jul;34(7):939-44
6610841
Lancet Neurol. 2006 Sep;5(9):735-41
16914401
Neurology. 2004 Nov 9;63(9):1624-8
15534246
Curr Med Res Opin. 2008 Sep;24(9):2561-74
18674411
Neurosci Lett. 1994 Jan 17;166(1):117-20
7514774
J Am Geriatr Soc. 1998 Nov;46(11):1437-48
9809769
CNS Drugs. 2003;17(12):905-14
12962529
Arch Intern Med. 2003 May 12;163(9):1069-75
12742805
J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1489-97
3221215
Eur J Neurol. 2000 Mar;7(2):159-69
10809936
Ann Neurol. 1980 May;7(5):486-8
7396427
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:8-18
9305508
Neurobiol Aging. 2006 Dec;27(12):1769-85
16300856
Neurology. 1994 Aug;44(8):1391-6
8058135
Neurosci Lett. 1999 Dec 31;277(3):169-72
10626840
J Hypertens. 2003 May;21(5):875-86
12714861
Ann N Y Acad Sci. 2000 Apr;903:522-8
10818547
Am J Occup Ther. 1999 Sep-Oct;53(5):471-81
10500855
Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S257-9
9072380
Med J Aust. 2008 Jul 21;189(2):105-9
18637782
Dement Geriatr Cogn Disord. 2004;17(1-2):29-34
14560062
Int J Clin Pract. 2002 Dec;56(10):791-6
12510954
Neurobiol Aging. 2003 Mar-Apr;24(2):213-9
12498955